Comparing oral vs. IV cefuroxime for kidney infection in pregnancy
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares a pill form of the antibiotic cefuroxime to an IV (intravenous) version for treating kidney infections during pregnancy. It aims to see if the oral option works just as well, which could make treatment easier and more comfortable for pregnant women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant, at least 18 years old, and less than 20 weeks along.
- You have been diagnosed with a kidney infection (pyelonephritis).
- You have symptoms like fever, back pain, or painful urination with lab signs of infection.
- You have not taken any antibiotics in the last 3 days.
- You are not allergic to the antibiotic cefuroxime.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving antibiotics through a vein for 3 days works as well as giving 3 days through a vein followed by 7 days by mouth for a first urinary tract infection (kidney infection). It may help your child recover safely while possibly reducing longer IV treatment.
This study looks at two antibiotics given during pregnancy: ceftriaxone (given as a shot or IV) for infections other than syphilis, and benzathine penicillin G (given as a shot) for syphilis. The goal is to learn more about how these medicines affect pregnant women and their babies.
This trial tests if a switch to pivmecillinam pills after IV antibiotics works as well as standard oral antibiotics for E. coli febrile urinary tract infections. It aims to simplify treatment for patients who are already stable.
This study tests a new antibiotic for children with difficult-to-treat urinary tract infections (UTIs). The medicine is given through an IV and may help when other antibiotics haven't worked.
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
This study tests an IV antibiotic (cefiderocol/xeruborbactam) in people with different levels of kidney function, including those on dialysis. It aims to see how the drug is processed by the body and whether it is safe.
Hear when a new Pyelonephritis in Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.